Zolazepam

This classification denotes a sedative and hypnotic with the molecular formula C14H13FN4O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G1R474U58U, chemically known as 4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-(3,4-e)(1,4)diazepin-7(1h)-one but generally known as zolazepam, which bears US NIH Compound Identifier 35775. European Medicines Agency schedules Zolazepam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00175MIG. The term ZOLAZEPAM is an International Non-Proprietary Name. ZOLAZEPAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule zolazepam under HS 29339940 and SITC 51577. As of Q4 2014, ZOLAZEPAM remains the US FDA Preferred Term for this commodity. Zolazepam bears US NLM identifiers UMLS ID C0043513 and NCI Concept Code C84252. SMILES: FC1C(C2=NCC(=O)N(C3N(NC(C23)C)C)C)CCCC1.